Eli Lilly (LLY) CEO says that the Co. will invest heavily in R&D with focus extending beyond obesity

Eli Lilly's CEO indicating a strong commitment to R&D can signal confidence in future growth avenues beyond obesity treatments, which may enhance long-term valuation.

Newsquawk StaffPublished On the live feed at 4 more headlines followed before this page went public
Newsquawk headlinesUTC

[PREVIEW] Japan Snap Election on Sunday, 8th February 2026: PM Takaichi's LDP expected to win

Yum! Brands (YUM) exec says Pizza Hut review is expected to conclude this year

Eli Lilly (LLY) CEO says that the Co. will invest heavily in R&D with focus extending beyond obesity

Fox's CEO (FOXA) says that they are focused on expanding podcast content and talent across fox news and the broader fox platform

US President Trump and Chinese President Xi held a call, according to Chinese State Media

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This shift in focus could either attract new investors looking for innovation or reassure existing ones about the company’s strategic vision in the competitive pharmaceuticals landscape.

Related headlines

The whole workspace, free to try.

Try it free